FY25 Peer Reviewed Medical Research Program (PRMRP) funding opportunities are now available!
For the fourth consecutive year, peripheral neuropathy (PN) has been renewed for research funding by the Department of Defense (DoD) Peer Reviewed Medical Research Program (PRMRP)’s $150 million fund for FY25. In advance of pre-application deadlines, we are sharing the FY25 funding mechanisms, award amounts, maximum direct costs and how to apply. Want to learn more about the process? Watch our past webinar with Cecilia Dupecher, Ph.D., for the PRMRP.
FY24 Peer Reviewed Medical Research Program award mechanisms and pre-application deadlines:
- Clinical Trial Award: June 9, 2025
- Technology/Therapeutic Development Award: June 9, 2025
Full application deadline: July 21, 2025
Additional information on Congressionally Directed Medical Research Programs
The Congressionally Directed Medical Research Programs (CDMRP) originated in 1992 via a Congressional appropriation to foster novel approaches to biomedical research in response to the expressed needs of its stakeholders-the American public, the military, and Congress. Check out their webinar series on types of funding opportunities offered, and strategies to increase the success of applications submitted to different CDMRP programs.
Background information
Since our formation in 2007, we have worked to advance peripheral neuropathy research to improve diagnosis, treatment, and management of this debilitating condition. In the first year for PN eligibility, more than $8 million in funding was awarded. Since then, over $19 million in funding has been awarded for PN research.
Get more information about the FY25 PRMRP, including submission instructions.
the Foundation for Peripheral Neuropathy is a non-profit organization committed to improving the lives of patients living with peripheral neuropathy. The organization helps accelerate the ability to diagnose, treat, prevent, and cure peripheral neuropathies through research funding and increased awareness of this condition. For questions, please reach out to the Foundation at [email protected].
